Ressources

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Practice Guidelines Treatments

covid19-sciencetable.ca Dernière mise à jour: février 23, 2022

The Impact of The COVID‑19 Pandemic on Chronic Disease Risk Factors

Product: — Evidence Synthesis Network

Disease Mechanism Epidemiology Infectious Diseases & Clinical Care

esnetwork.ca Dernière mise à jour: février 6, 2022

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Practice Guidelines Treatments

covid19-sciencetable.ca Dernière mise à jour: janvier 21, 2022

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Practice Guidelines Treatments

covid19-sciencetable.ca Dernière mise à jour: janvier 18, 2022

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Practice Guidelines Treatments

covid19-sciencetable.ca Dernière mise à jour: janvier 8, 2022

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Practice Guidelines Treatments

covid19-sciencetable.ca Dernière mise à jour: Décembre 22, 2021

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Infectious Diseases & Clinical Care

covid19-sciencetable.ca Dernière mise à jour: novembre 24, 2021

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Practice Guidelines Treatments

covid19-sciencetable.ca Dernière mise à jour: novembre 24, 2021

Evidence-Based Recommendations on the Use of Anti-SARS-CoV-2 Monoclonal Antibodies (Casirivimab + Imdevimab, and Sotrovimab) for Adults in Ontario

Product: — Science Table

Infectious Diseases & Clinical Care

covid19-sciencetable.ca Dernière mise à jour: novembre 24, 2021

Design Strategies To Prevent Respiratory Infection In Congregate Care Settings

Product: — Evidence Synthesis Network

Community Prevention & Transmission Infectious Diseases & Clinical Care Practice Guidelines Public Prevention Transmission

esnetwork.ca Dernière mise à jour: novembre 4, 2021